Fluoroscan InSight FD Mini C-Arm
extremities imaging system
extremities imaging system
Hologic Inc. unveils new fluoroscopy system at RSNA 2017
December 01, 2017
by John R. Fischer, Senior Reporter
CHICAGO — Hologic Inc. unveiled its Fluoroscan InSight FD Mini C-Arm extremities imaging system this week at the 2017 Radiological Society of North America (RSNA) annual conference in Chicago.
Equipped with the recently released InSight 6.1 software, the system offers a variety of capabilities, including superior positioning, enhanced imaging and easy handling, for meeting the needs of extremity surgeons.
"We are further improving the imaging experience for the orthopedic extremity surgeons," Rajesh Sivakumar, associate product director for fluoroscan skeletal marketing at Hologic, told HCB News. "We are now providing a high-resolution mode that enables the surgeons to see the microfractures and trabecular details in the bone very clearly. We are introducing a low-dose mode that enables physicians to reduce the radiation dosage by 50 percent, compared to our auto mode, mostly aimed for intraoperative imaging."
The system consists of an easy-to-use, intuitive touchscreen interface along with a manual work list entry feature and an autosave option. The high-resolution imaging option enables the use of full-detector resolution, while the low-dose mode allows users to reduce dose rates and still obtain clinically equivalent images.
Fluroscan InSight FD is equipped with a rotating flat detector panel, the position of which can be optimized to allow physicians to image long bones while keeping radiation at a minimum. Additional features include a redesigned monitor arm and rail for easy transportation, an integrated keyboard and reduced OR workspace interruptions.
Using the system, physicians can also provide a continuum of care by assessing bone quality to determine if further evaluations, such as for body composition or bone densitometry, are required.
"Fluoroscan InSight FD enables Hologic to provide the orthopedic surgeons with a comprehensive tool to detect and treat extremities fractures,” Sivakumar said. “It is all about enabling patients to live stronger, healthier lives."
The software is FDA approved and was released in October. The hardware is also FDA approved, with its release planned tentatively for early 2018.
Equipped with the recently released InSight 6.1 software, the system offers a variety of capabilities, including superior positioning, enhanced imaging and easy handling, for meeting the needs of extremity surgeons.
"We are further improving the imaging experience for the orthopedic extremity surgeons," Rajesh Sivakumar, associate product director for fluoroscan skeletal marketing at Hologic, told HCB News. "We are now providing a high-resolution mode that enables the surgeons to see the microfractures and trabecular details in the bone very clearly. We are introducing a low-dose mode that enables physicians to reduce the radiation dosage by 50 percent, compared to our auto mode, mostly aimed for intraoperative imaging."
The system consists of an easy-to-use, intuitive touchscreen interface along with a manual work list entry feature and an autosave option. The high-resolution imaging option enables the use of full-detector resolution, while the low-dose mode allows users to reduce dose rates and still obtain clinically equivalent images.
Fluroscan InSight FD is equipped with a rotating flat detector panel, the position of which can be optimized to allow physicians to image long bones while keeping radiation at a minimum. Additional features include a redesigned monitor arm and rail for easy transportation, an integrated keyboard and reduced OR workspace interruptions.
Using the system, physicians can also provide a continuum of care by assessing bone quality to determine if further evaluations, such as for body composition or bone densitometry, are required.
"Fluoroscan InSight FD enables Hologic to provide the orthopedic surgeons with a comprehensive tool to detect and treat extremities fractures,” Sivakumar said. “It is all about enabling patients to live stronger, healthier lives."
The software is FDA approved and was released in October. The hardware is also FDA approved, with its release planned tentatively for early 2018.